Funding This study was supported by a Commercial Development & Industry Partnership (CDIP) grant (CT20584-University of Sydney and Whiteley Corporation) and a Department of Industry, Innovation and Science (Innovative Manufacturing CRC Ltd.) and Whiteley Corporation co-funded project grant A Novel Approach to Biofilm Disruption and Removal (IMCRC/WLY/08052019.1)
In 2022, one study discovered that DEX postconditioning could enhance GSH and GPX4 levels in the myocardium, preventing cardiac damage and ferroptosis caused by I/R [232]
"Glutathione metabolism and its implications for health"
Research on Peptide 157 indicates that it is safe for use as studies have shown no significant adverse effects, making it a viable option for those looking to improve their muscle recovery and performance
By following a tailored approach, CMD can adjust the peptide selection, administration schedule, dosing, and treatment duration
Psychiatry 16, 12341246